Last10K.com

Biorestorative Therapies, Inc. (BRTX) SEC Filing 10-K Annual report for the fiscal year ending Wednesday, December 31, 2014

SEC Filings

BRTX Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

BRTX Annual Reports

BRTX Quarterly Reports

BRTX Corporate News

BRTX Registration of Securities

Biorestorative Therapies, Inc.

HISTORY TOOLS
CIK: 1505497 Ticker: BRTX
Document And Entity Information (USD $)
 12 Months Ended
Dec. 31, 2014
Mar. 30, 2015
Jun. 30, 2014
Document Information [Line Items]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2014    
Document Fiscal Year Focus 2014    
Document Fiscal Period Focus FY    
Entity Registrant Name BioRestorative Therapies, Inc.    
Entity Central Index Key 0001505497    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Filer Category Smaller Reporting Company    
Entity Public Float     $ 5,692,745dei_EntityPublicFloat
Trading Symbol BRTX    
Entity Common Stock, Shares Outstanding   37,149,052dei_EntityCommonStockSharesOutstanding  

View differences made from one year to another to evaluate Biorestorative Therapies, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Biorestorative Therapies, Inc..

Continue

Assess how Biorestorative Therapies, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Biorestorative Therapies, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2015 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Stockholders' Equity (deficiency)
Consolidated Statements Of Operations
Going Concern And Management's Plans - Additional Information (detail)
Loss Before Income Taxes (detail)
Accrued Expenses And Other Current Liabilities
Accrued Expenses And Other Current Liabilities (detail)
Accrued Expenses And Other Current Liabilities (tables)
Accrued Expenses And Other Current Liabilities - Additional Information (detail)
Amortization Of Intangible Assets (detail)
Black-scholes Option Pricing Model To Stock Option Granted, Weighted Average Assumptions (detail)
Black-scholes Option Pricing Model To Warrant Granted, Weighted Average Assumptions (detail)
Business Organization And Nature Of Operations
Business Organization And Nature Of Operations - Additional Information (detail)
Calculation Of Weighted Average Dilutive Common Shares (detail)
Commitments And Contingencies
Commitments And Contingencies - Additional Information (detail)
Deferred Tax Assets (detail)
Going Concern And Management's Plans
Income Tax Provision (benefit) (detail)
Income Taxes
Income Taxes (tables)
Income Taxes - Additional Information (detail)
Information Related To Common Stock Award Expense (detail)
Information Related To Stock Option Expense (detail)
Information Related To Stock Options (detail)
Intangible Assets
Intangible Assets (detail)
Intangible Assets (tables)
Intangible Assets - Additional Information (detail)
Notes Payable
Notes Payable (detail)
Notes Payable (tables)
Notes Payable - Additional Information (detail)
Property And Equipment
Property And Equipment (detail)
Property And Equipment (tables)
Property And Equipment - Additional Information (detail)
Statutory Federal Income Tax Rate (detail)
Stockholders' Deficiency
Stockholders' Deficiency (tables)
Stockholders' Deficiency - Additional Information (detail)
Subsequent Events
Subsequent Events- Additional Information (detail)
Summarized Information Related To Stock Warrants (detail)
Summary Of Common Stock Award Activity (detail)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (policies)
Summary Of Significant Accounting Policies (tables)
Summary Of Significant Accounting Policies - Additional Information (detail)
Summary Of Stock Option Activity (detail)
Summary Of Warrant Activity (detail)
Ticker: BRTX
CIK: 1505497
Form Type: 10-K Annual Report
Accession Number: 0001144204-15-020255
Submitted to the SEC: Tue Mar 31 2015 5:13:22 PM EST
Accepted by the SEC: Tue Mar 31 2015
Period: Wednesday, December 31, 2014
Industry: Health And Allied

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/brtx/0001144204-15-020255.htm